Home » Topics » Regulatory » Health Canada

Health Canada
RSS

Breo Ellipta approved in Canada for chronic obstructive pulmonary disease

July 11, 2013

Canadian acceptance of MycoTool for release testing of Roche product

June 18, 2013

Astellas launches Xtandi in Canada for castration-resistant prostate cancer

June 14, 2013

Aerocrine's Niox Mino device approved in Canada

April 17, 2013

Canadian approval for Hologic's HPV assays

April 9, 2013

Health Canada approves mirabegron

March 11, 2013

Health Canada declines to approve Theratechnologies' NDS for Egrifta

March 5, 2013

Santhera considering strategic options following decisions regarding Catena and Raxone

March 4, 2013

Health Canada grants approval to Adcetris for two lymphoma indications

Feb. 4, 2013

Health Canada approves Afinitor for advanced breast cancer

Jan. 17, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...